In vitro and in vivo erosion of two different hydrophilic gel matrix tablets

被引:38
作者
Abrahamsson, B
Alpsten, M
Bake, B
Larsson, A
Sjogren, J
机构
[1] Sahlgrens Univ Hosp, Dept Radiat Phys, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Clin Physiol, S-41345 Gothenburg, Sweden
[3] Astra Hassle AB, Molndal, Sweden
关键词
hydrophilic matrix tablets; tablet erosion; gamma scintigraphy; in vitro in vivo correlation;
D O I
10.1016/S0939-6411(98)00002-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present work was to establish in vivo predictive in vitro tests for the tablet erosion of two different compositions (A and B) of hydrophilic matrix tablets based on hydroxypropyl methylcellulose. The tablet erosion was studied in a modified USP IT apparatus at different agitation intensities and ionic strengths according to 2(2) factorial design. The in vivo tablet erosion was studied in 8 healthy human volunteers by gamma scintigraphy after administration of the tablets together with breakfast. In vitro agitation intensity increased the erosion rate for both tablets whereas increased ionic strength caused a slower rate for tablet A and a faster rate for tablet B. The choice of in vitro testing conditions proved to be critical for the attainment of in vivo predictive results. The best in vitro/in vivo correlation for the two formulations was obtained at a paddle stirring rate of 140 rpm and a ionic strength of 0.14 obtained by addition of sodium chloride. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 18 条
  • [1] ABSORPTION, GASTROINTESTINAL TRANSIT, AND TABLET EROSION OF FELODIPINE EXTENDED-RELEASE (ER) TABLETS
    ABRAHAMSSON, B
    ALPSTEN, M
    HUGOSSON, M
    JONSSON, UE
    SUNDGREN, M
    SVENHEDEN, A
    TOLLI, J
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (05) : 709 - 714
  • [2] ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
  • [3] Butler J., 1995, Pharmaceutical Research (New York), V12, pS250
  • [4] CHRISTENSEN GI, 1962, Patent No. 3065143
  • [5] DAHLINDER LE, 1973, ACTA PHARM SUEC, V10, P323
  • [6] Langenbucher F., 1976, PHARM IND, V38, P472
  • [7] LAPIDUS H, 1968, J PHARM SCI, V57, P8
  • [8] Characterization of fluids from the stomach and proximal jejunum in men and women
    Lindahl, A
    Ungell, AL
    Knutson, L
    Lennernas, H
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (04) : 497 - 502
  • [9] DRUG-RELEASE FROM HYDROCOLLOID EMBEDDINGS WITH HIGH OR LOW SUSCEPTIBILITY TO HYDRODYNAMIC STRESS
    LINDNER, WD
    LIPPOLD, BC
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (11) : 1781 - 1785
  • [10] MELIA CD, 1991, CRIT REV THER DRUG, V8, P395